Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD.
Saved in:
| Title: | Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD. |
|---|---|
| Authors: | Strassman AM; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center.; Harvard Medical School, Boston, Massachusetts, USA., Melo-Carrillo A; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center.; Harvard Medical School, Boston, Massachusetts, USA., Houle TT; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, USA., Adams A; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, USA., Brin MF; Allergan, an AbbVie Company, Irvine, CA, USA.; Dept of Neurology, University of California, Irvine, USA., Burstein R; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center.; Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | Cephalalgia : an international journal of headache [Cephalalgia] 2022 Aug; Vol. 42 (9), pp. 933-943. Date of Electronic Publication: 2022 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 8200710 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1468-2982 |
|---|---|
| DOI: | 10.1177/03331024221083544 |
